Package Leaflet: Information for the Patient
Rabeprazol SUN 20 mg Gastro-Resistant Tablets EFG
Rabeprazole Sodium
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Rabeprazol SUN contains the active ingredient rabeprazole sodium. Rabeprazole belongs to a class of medicines known as “Proton Pump Inhibitors” (PPIs), which work by reducing the amount of acid produced by the stomach.
Rabeprazol SUN tablets are used for the treatment of:
Do not take Rabeprazol SUN
Do not take Rabeprazol SUN if you are in any of the above situations. If you are not sure, consult your doctor or pharmacist before taking Rabeprazol SUN.
See also the section on Pregnancy and breastfeeding.
Children
Rabeprazol SUN should not be given to children.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rabeprazol SUN:
If you get a rash, especially in areas of the skin exposed to the sun, consult your doctor as soon as possible, as it may be necessary to stop treatment with Rabeprazol SUN. Remember to mention any other symptoms you may notice, such as joint pain. If you are unsure about the above, consult your doctor or pharmacist before taking this medicine.
If you experience severe diarrhea (watery or bloody) with symptoms such as fever, abdominal pain, or sensitivity, stop taking Rabeprazol SUN and see your doctor immediately.
If you are taking proton pump inhibitors like Rabeprazol SUN, especially for more than a year, you may have a slightly increased risk of hip, wrist, and spine fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
During treatment with rabeprazole, kidney inflammation can occur. The signs and symptoms include: decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, rash, and joint stiffness. You should report these signs to your doctor.
Using Rabeprazol SUN with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription, including herbal medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medicine during pregnancy or breastfeeding.
Driving and using machines
You may feel drowsy while taking Rabeprazol SUN. If this happens, do not drive or use tools or machines.
Rabeprazol SUN contains Allura Red (E 129)
This medicine may cause allergic reactions because it contains the colorant Allura Red (E 129).
It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking this medicine
Adults and elderly patients
For “Gastroesophageal Reflux Disease” (GERD)
Treatment of moderate to severe symptoms (Symptomatic GERD)
Treatment of more severe symptoms (Erosive or Ulcerative GERD)
Long-term treatment of symptoms (Maintenance GERD)
For stomach ulcers (peptic ulcers)
For intestinal ulcers (duodenal ulcers)
For ulcers caused by H. Pylori infection and to prevent recurrence
Zollinger-Ellison Syndrome where there is an excess of acid in the stomach
If you are on long-term treatment, you will need to see your doctor at regular intervals for dose and symptom review.
Children.This medicine should not be given to children.
Patients with liver problems.Your doctor will take special care when starting and during treatment with Rabeprazol SUN.
If you take more Rabeprazol SUN than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Rabeprazol SUN
If you stop taking Rabeprazol SUN
Relief of symptoms usually occurs before the ulcer is completely healed. It is important that you do not stop treatment until your doctor tells you to.
If you have any further questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects are usually mild and improve without you stopping treatment.
Stop taking Rabeprazol SUN and see your doctor immediately if you notice any of the following side effects - you may need urgent medical treatment:
These side effects are rare (affect less than 1 in 1,000 people).
These side effects are very rare (may affect between 1 and 10 in 10,000 people).
Other possible side effects:
Common (may affect between 1 and 10 in 100 people)
Uncommon (may affect between 1 and 10 in 1,000 people)
Rare (may affect between 1 and 10 in 10,000 people)
Other possible side effects (frequency not known)
Do not worry about the list of side effects. You may not experience any of them.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es/. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging and blister. The expiration date is the last day of the month indicated.
Do not store above 25°C. Do not refrigerate or freeze. Store in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Rabeprazol SUN Composition
Core: mannitol, heavy magnesium oxide, low-substituted hydroxypropyl cellulose, hydroxypropyl cellulose (L), magnesium stearate.
Subcoating: ethylcellulose (7cps), light magnesium oxide, hydroxypropyl cellulose (L).
Enteric coating: hypromellose phthalate, diacetylated monoglycerides, talc, titanium dioxide (E 171), yellow iron oxide (E 172).
Printing ink: shellac, Allura Red Aluminum Lacquer (E 129), titanium dioxide (E 171),
Propylene glycol
Product Appearance and Packaging Content
Rabeprazol SUN 20 mg: yellow, round, biconvex, gastro-resistant tablet marked with "RA" on one face and smooth on the other face.
The tablets are presented in packages containing: 7, 14, or 28 gastro-resistant tablets.
Not all packages are marketed.
Marketing Authorization Holder and Manufacturer:
Sun Pharmaceutical Industries Europe B.V.,
Polarisavenue 87,
2132JH Hoofddorp,
Netherlands
Manufacturer:
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
TERAPIA S.A.
124 Fabricii Street
400 632 Cluj Napoca,
Romania
Alkaloida Chemical Company Zrt.
Kabay Janós u. 29.,
Tiszavasvári - 4440
Hungary
Local Representative
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya 53-55
08007 Barcelona. Spain
Tel.:+34 93 342 78 90
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
France: Rabeprazole SUN 20 mg, gastro-resistant tablet
Italy: Rabeprazolo SUN 20 mg gastro-resistant tablets
Netherlands: Rabeprazolnatrium Ranbaxy 20 mg, gastro-resistant tablet
Romania: Rabeprazol Terapia 20 mg gastro-resistant tablets
Spain: Rabeprazol SUN 20 mg gastro-resistant tablets EFG
Date of the Last Revision of this Leaflet:September 2022
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/